Posts by J-Star Research
New State-of-the-Art Crystallization and Drug Product Facility
Porton is excited to announce construction of a new, state-of-the-art Crystallization and Drug Product facility in Cranbury, NJ. The new building is projected to open in Q4 of 2022. This…
Read MorePharma Crystallization Summit 2022 Technical Program Now Available
We are very excited to announce the technical program of Pharma Crystallization Summit 2022. This year’s Summit is in-person only and the seats are limited. We cordially invite CMC leaders/managers…
Read MoreMetasTx LLC Raises Funds, Engages J-STAR Research as Manufacturing Partner, and Advances Phase One Development
BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) — MetasTx LLC is driven to create novel therapeutics to treat and prevent metastasis of cancers. Harvey Homan, CEO and Co-Founder has successfully presented…
Read More3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series
J-Star Research is pleased to announce our collaboration in the 3rd Edition of Fundamentals of Solid Formulation (FSF2022) webinar series, featuring an impressive line-up of speakers and topics. This is…
Read MoreJ-Star Research’s subject matter experts presenting at 2021 AAPS PharmSci360 in Philadelphia
J-Star Research’s subject matter experts are presenting at 2021 AAPS PharmSci360, in Philadelphia, PA, on October 17-20. Our synergistically integrated DS-DP team will discuss the enabling technologies and unique capabilities…
Read MorePorton/J-Star at 2021 SAPA Annual Conference
We are proud to announce that Porton’s Chairman and CEO, Niafeng (Oliver) Ju (EMBA), and San Kiang (Ph.D.), CTO of Porton/J-Star Research, will be Keynote Speaker and CMC Speaker, respectively,…
Read MoreJ-Star Research Exhibiting at CPhI North America August 10-12
Visit J-Star Research and Porton at Booth 2243 from August 10th to 12th at this month’s CPhINorthAmerica event. Our team will be available to discuss your drug development needs. Schedule your meeting…
Read MoreCfPC Announces Program of 2021 Pharmaceutical Crystallization Summit
The Center for Pharma Crystallization (CfPC) at J-Star Research, Inc., a US based subsidiary of Porton Pharma Solutions, is pleased to announce the program of the 2nd annual Pharmaceutical Crystallization…
Read MorePorton awards Industrial Crystallization Scholarship
On Saturday, June 6, Porton and Tianjin University National Engineering Research Center of Industrial Crystallization Technology (CICT) announced a school-enterprise strategic cooperation to jointly advance CICT’s resource investment, technology development,…
Read MorePorton begins construction on highly anticipated Drug Product GMP site
May 25, 2002, Shanghai, China. Porton Pharma Solutions Ltd., one of the world’s leading CDMOs, today celebrated the groundbreaking of its new drug product GMP site. Construction of the facility…
Read More